Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets: 2014-2024

Historic Other Non-Current Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 10 years, with Dec 2024 value amounting to $501,000.

  • Viridian Therapeutics, Inc.\DE's Other Non-Current Assets rose 77.96% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 77.96%. This contributed to the annual value of $501,000 for FY2024, which is 17.05% down from last year.
  • According to the latest figures from FY2024, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets is $501,000, which was down 17.05% from $604,000 recorded in FY2023.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets registered a high of $1.5 million during FY2021, and its lowest value of $1,000 during FY2020.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets averaged around $695,667, with its median value being $604,000 (2023).
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets soared by 149,000.00% in 2021 and then tumbled by 38.49% in 2023.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets (Yearly) stood at $1,000 in 2020, then spiked by 149,000.00% to $1.5 million in 2021, then tumbled by 34.14% to $982,000 in 2022, then crashed by 38.49% to $604,000 in 2023, then declined by 17.05% to $501,000 in 2024.